154 related articles for article (PubMed ID: 11579682)
1. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
2. Silver-Staining Nucleolar Organizer Region Quantification in Pituitary Adenomas.
Sowiska-Klencka D; Klencki M; Dedecjus M; Lewiski A; Pawlikowski M
Endocr Pathol; 2000; 11(2):173-178. PubMed ID: 12114823
[TBL] [Abstract][Full Text] [Related]
3. Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary.
Stefaneanu L; Horvath E; Kovacs K
Mod Pathol; 1989 May; 2(3):192-9. PubMed ID: 2474815
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods.
Augustynowicz A; Dziecioł J; Barwijuk-Machała M; Dadan J; Puchalski Z; Sulkowski S
Folia Histochem Cytobiol; 2004; 42(3):165-8. PubMed ID: 15493577
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
8. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
9. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma.
Pawlikowski M; Gruszka A; Kurnatowska I; Winczyk K; Kunert-Radek J; Radek A
Folia Histochem Cytobiol; 2006; 44(1):37-41. PubMed ID: 16584090
[TBL] [Abstract][Full Text] [Related]
11. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
Kida Y; Takano Y; Okudaira M
J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
[TBL] [Abstract][Full Text] [Related]
14. Argyrophilic nucleolar organizer regions in colorectal malignancy: application of typing by their density.
Iwashita T; Mori H; Ito Y; Obashi A; Sugimoto K; Tei H; Hirata I; Oshiba S
Pathol Int; 1996 Mar; 46(3):204-10. PubMed ID: 10846571
[TBL] [Abstract][Full Text] [Related]
15. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.
Shibuya M; Saito F; Miwa T; Davis RL; Wilson CB; Hoshino T
Acta Neuropathol; 1992; 84(2):178-83. PubMed ID: 1381860
[TBL] [Abstract][Full Text] [Related]
16. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
18. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence.
Hsu DW; Hakim F; Biller BM; de la Monte S; Zervas NT; Klibanski A; Hedley-Whyte ET
J Neurosurg; 1993 May; 78(5):753-61. PubMed ID: 8096873
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression.
Slowińska-Klencka D; Klencki M; Popowicz B; Sporny S; Lewiński A
Histol Histopathol; 2004 Jul; 19(3):785-92. PubMed ID: 15168341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
